SubscribeLatest 5 articles from heartwire
- Sen Grassley questions top medical schools about ghostwriting
Nov 20, 2009 13:15 EDT - Stroke incidence related to PCI steady over 15 years
Nov 20, 2009 13:00 EDT - ALLHAT investigators report 10-year follow-up and stand by diuretics as first step antihypertensive treatment
Nov 19, 2009 14:00 EDT - Oral anticoagulants REDEEMed? Daily dabigatran "safe" with dual antiplatelets after MI
Nov 19, 2009 11:00 EDT - EFFECT: Public reporting of hospital performance improves quality of care?
Nov 19, 2009 10:00 EDT
Dabigatran: Crossing a remarkable threshold
Posted Oct 14, 2009
at 11:00 AM, EDT
by Eric Topol
The exciting results of the RE-LY trial appear to mark the beginning of a new era in anticoagulation for atrial fibrillation. Will dabigatran be the drug to replace warfarin, at last? How do you think these findings will improve patient care?
Disclosure: I have no relationship with the dabigatran's manufacturer (Boehringer Ingleheim) or any other forthcoming oral anticoagulant program in clinical development (DTI, Factor Xa, etc).
See:
RE-LY: Oral antithrombin dabigatran outshines warfarin in atrial fib
Best of Barcelona: PLATO and RE-LY
RE-LY: An obituary for Warfarin?
Previous postsBillets précédents
Ezetimibe in ARBITER 6-HALTS: What lessons can we learn?
No commentsAucun commentaire |
Posted Nov 16, 2009
at 05:00 PM, EDT by Eric Publié le 11.16.2009 à 17h00 par Eric
at 05:00 PM, EDT by Eric Publié le 11.16.2009 à 17h00 par Eric
Antiplatelet therapy: A step forward with individualized medicine
5 comments5 commentaires |
Posted Sep 22, 2009
at 10:30 AM, EDT by Eric Publié le 09.22.2009 à 10h30 par Eric
at 10:30 AM, EDT by Eric Publié le 09.22.2009 à 10h30 par Eric
Cash for clunkers, cash for lowering obesity rates
4 comments4 commentaires |
Posted Aug 24, 2009
at 01:50 PM, EDT by Eric Publié le 08.24.2009 à 13h50 par Eric
at 01:50 PM, EDT by Eric Publié le 08.24.2009 à 13h50 par Eric
Preventing rehospitalization for heart failure
3 comments3 commentaires |
Posted Jul 28, 2009
at 01:25 PM, EDT by Eric Publié le 07.28.2009 à 13h25 par Eric
at 01:25 PM, EDT by Eric Publié le 07.28.2009 à 13h25 par Eric
Low-dose aspirin for primary prevention
4 comments4 commentaires |
Posted Jun 17, 2009
at 02:03 PM, EDT by Eric Publié le 06.17.2009 à 14h03 par Eric
at 02:03 PM, EDT by Eric Publié le 06.17.2009 à 14h03 par Eric
Also from theheart.org
Blogs I read
Who's talking
|
Eric J Topol MD
Director, Scripps Translational Science Institute The Gary and Mary West Chair of Innovative Medicine Chief Academic Officer, Scripps Health La Jolla, CA |
CommentsCommentaires